XOFLUZA FILM-COATED TABLET 40MG Μαλαισία - Αγγλικά - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

xofluza film-coated tablet 40mg

roche (malaysia) sdn. bhd. - baloxavir marboxil -

VECTIBIX 20 MGML Ισραήλ - Αγγλικά - Ministry of Health

vectibix 20 mgml

amgen europe b.v. - panitumumab - concentrate for solution for infusion - panitumumab 20 mg / 1 ml - panitumumab - in combination with chemotherapy for the treatment of unresectable, advanced or recurrent colorectal cancer (mcrc) with wild-type ras.monotherapy for the treatment of patients with metastatic colorectal carcinoma with wild-type ras after failure of fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.

ERTRACER, FLUDEOXYGLUCOSE (18F) Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

ertracer, fludeoxyglucose (18f)

m2i limited - fludeoxyglucose (18f) - solution for injection - 1-13 gbq/ml

ROFERON A Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

roferon a

roche products ltd - interferon alfa-2a - solution for injection - 3miu/0.5ml %v/v

ROFERON A Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

roferon a

roche products ltd - interferon alfa-2a - solution for injection - 4.5miu/0.5 %v/v

ROFERON A Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

roferon a

roche products ltd - interferon alfa-2a - solution for injection - 6miu/ml %v/v

ROFERON A Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

roferon a

roche products ltd - interferon alfa-2a - solution for injection - 18miu/0.6m %v/v

ROFERON-A PRE-FILLED SYRINGE 18MIU/0.5ML Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

roferon-a pre-filled syringe 18miu/0.5ml

roche products ltd - interferon alfa-2a - solution for injection - 18 miu/0.5 %v/v

ROFERON - A 3 MIU/0.5 ML Ισραήλ - Αγγλικά - Ministry of Health

roferon - a 3 miu/0.5 ml

roche pharmaceuticals (israel) ltd - interferon alfa 2a 3 miu / 0.5 ml - solution for injection - interferon alfa-2a - condylumata acuminata. hepatitis b,c. hairy cell leukemia. cml. aids related kaposis sarcoma. renal cell carcinoma.follicular non-hodgkin's lymphoma. patients with ajcc stage ii malignant melanoma (breslow tumour thickness > 1.5 mm, no lymph node involvement or cutaneous spread) who are free of disease after surgery.

ERTRACER FLUDEOXYGLUCOSE (18F) INJECTION, SOLUTION 1-13 GBq/ml Solution for Injection Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

ertracer fludeoxyglucose (18f) injection, solution 1-13 gbq/ml solution for injection

m2i limited - fludeoxyglucose (18f) - solution for injection - 1-13 gbq/ml